HALISTER: Gilead’s Replacement HIV Drug Improves Kidney Effects in Study

Gilead’s Replacement HIV Drug Improves Kidney Effects in Study

Alert: HALISTER Source: BN (Bloomberg News)

Tickers GILD US (Gilead Sciences Inc)

People Brian Abrahams (Wachovia Securities Inc) John Milligan (Gilead Sciences Inc)

Topics AIDS Infectious Diseases

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283

HALISTER: France’s Nuclear Decline Exposed as Areva Confronts Cash Crunch

France’s Nuclear Decline Exposed as Areva Confronts Cash Crunch

Alert: HALISTER Source: BN (Bloomberg News)

Tickers AREVA FP (Areva SA) EDF FP (Electricite de France SA)

People Bryan Garnier Am (Bryan Garnier & Co Ltd) Erik Maris (Messier Maris & Associes) Gerard Mestrallet (GDF Suez) Jean-Bernard Levy (Electricite de France SA) Juan Rodriguez (Alphavalue Sas)

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283

HALISTER: Lilly to Introduce Lantus Copy in Europe After Patent Expiry (1)

Lilly to Introduce Lantus Copy in Europe After Patent Expiry (1)

Alert: HALISTER Source: BN (Bloomberg News)

Tickers LLY US (Eli Lilly & Co) SAN FP (Sanofi)

People Christopher Viehbacher (European Federation Of Pharmaceutical Industries & Assn)

Topics Diabetes

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283